Impact of timing of biochemical failure on the eventual development of clinical failure after definitive treatment with brachytherapy or external beam radiotherapy for prostate cancer.

Authors

null

Jay P. Ciezki

Cleveland Clinic, Cleveland, OH

Jay P. Ciezki , Chandana A. Reddy , Eric A. Klein , James Ulchaker , Kenneth Angermeier , Rahul D. Tendulkar , Kevin L. Stephans , Steven C. Campbell , Andrew J. Stephenson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 53)

DOI

10.1200/jco.2015.33.7_suppl.53

Abstract #

53

Poster Bd #

C20

Abstract Disclosures

Similar Posters

First Author: Jay P. Ciezki

Poster

2021 Genitourinary Cancers Symposium

Intraprostatic calcification and biochemical recurrence in men treated with Cs-131 prostate brachytherapy.

Intraprostatic calcification and biochemical recurrence in men treated with Cs-131 prostate brachytherapy.

First Author: Michael D Schad

Poster

2024 ASCO Genitourinary Cancers Symposium

Long-term outcomes for patients with radiorecurrent prostate cancer treated with salvage combination IMRT and brachytherapy.

Long-term outcomes for patients with radiorecurrent prostate cancer treated with salvage combination IMRT and brachytherapy.

First Author: Michael J. Dattoli

Poster

2023 ASCO Genitourinary Cancers Symposium

Long-term rates of biochemical recurrence after primary external beam radiation therapy (EBRT) for prostate cancer.

Long-term rates of biochemical recurrence after primary external beam radiation therapy (EBRT) for prostate cancer.

First Author: Domenique Escobar